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of  immune cellular  infiltration  in the mucosa of 
ileum and colon, but the expression of the genes 











Eimeria bovis  and E zuernii  are  the  economi-
cally most important of the twenty-one or so coc-









The  bovine  immune  response  to  infection with 
Eimeria  seems  to  follow a  sequential Th1  then 
Th2  pattern,  although  the  effector mechanism 



















et  al.  2008)  and  augmented  by  immune  serum 
(Taubert  et  al.  2009).  More  recently,  the  roles 
of  neutrophils  in  resistance  to  bovine Eimeria 

















in mice.  In both cases,  it was  found that toltra-
zuril  did  not  interfere with  the  development  of 
normal immunity, and Grief (2000) demonstrated 
enhanced antibody production following toltrazuril 
treatment.  However,  no  data  are  yet  available 
regarding the effect of toltrazuril on immunity to 
coccidial infection in cattle. This is an important 









immunohistochemistry  and  gene  expression  of 
cytokines and chemokines. 































Calves  were  attended  every  morning  between 
07:00  and  08:30  h  and  every  evening  between 




















































































Allocation to groups and treatments
Calves were allocated to groups on day +14. After 
feeding,  calves  were  weighed  and  the  weights 
recorded. Animals were ranked by weight,  from 
highest (69.5 kg) to lowest (49.0 kg). A coin was 



































Faecal oocyst counts and differentiation
Faecal oocyst  counts with morphological differ-


































































































































































MM1A VMRD CD3 IgG1 Tcells 1/800 Davisetal.1993

































Oocyst counts: Arithmetic mean oocyst  counts 
for each treatment group were calculated for each 
day that oocyst counts were measured. Geometric 
means  of  the  (oocyst  count  +1) were  also  calcu-
lated. For regression analysis, the highest oocyst 






























was  calculated  for  each  calf.  This  variable was 






effect  of  treatment with  statistical  significance 
taken as p < 0.05.













































Mean  (and  SEM)  of  faecal  consistency  scores 
are  shown  in  Fig.  3.  Faecal  consistency  scores 
increased from 1 in both groups after infection at 
day 0 to peak on day +18 (treatment + 4 d) at 2.6 in 




















Trial day (D0 = infection, D+14 = treatment)
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3 Control 4.9 81,000 1,4171 4 2.1 0 1
6 Control –4.6 48,600 10,679 4 2.2 0 1
7 Control 4 150,000 21,607 4 1.8 0 1
10 Control 5.8 98,000 17,064 3 1.7 0 0
14 Control 2.2 14,400 2,671 4 1.7 1 1
16 Control 6 51,700 5,950 3 1.8 1 0
18 Control 5.5 79,600 15,743 3 1.9 0 0
21 Control –0.4 275,200 65,250 4 2.0 1 1
4 Toltrazuril 5.2 100 14 3 1.4 0 0
5 Toltrazuril 7.2 2,300 236 2 1.3 0 0
8 Toltrazuril 4.4 34,200 2,457 3 1.8 0 0
11 Toltrazuril 4.1 600 57 3 1.4 0 0
13 Toltrazuril 4.4 1,900 264 3 1.1 0 0
17 Toltrazuril 4 5,400 550 2 1.3 0 0
19 Toltrazuril 3.8 1,400 150 2 1.1 0 0












Trial day (D0 = infection, D+14 = treatment)































































































































































































































































































































































































































Associations of measured variables with 
nodular change in the colon












































































































































































antibody  production  in  chickens  infected  with 
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